What this means
This is a planned study that is still recruiting people, so it has no results yet. It will compare a leave-on face product with a standard moisturizer after laser treatment.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 40–70
- Where
- 2 sites, including California, Tennessee
The science
- Registered title
- Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser
- Trial ID
- NCT07718347 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Immediate Post-Treatment Care, Aging Mid-Face, Aging
- What is tested
- ariessence pure PDGF+™ is a sterile aqueous formulation containing Hyaluronic Acid and pure platelet-derived growth factor (PDGF).
- Sponsor
- Lynch Regenerative Medicine
- Ages
- 40 Years to 70 Years
- Dates
- First posted Jul 21, 2026 · updated Jul 21, 2026
Registry summary
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
Sites (2)
- Laser & Skin Surgery Medical Group, Sacramento, California, United States
- The Practice of Brian S. Biesman, MD, Nashville, Tennessee, United States